FARESTON Side Effects

7015563-X | Atrial Fibrillation, Bradycardia, Decreased Appetite, Dehydration, Hypokalaemia, Loss Of Consciousness, Nasopharyngitis, Torsade De Pointes
on Sep 06, 2010 Female patient from JAPAN , 75 years of age, was diagnosed with breast cancer stage i and was treated with Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), bradycardia, decreased appetite, dehydration, hypokalaemia, loss of consciousness, nasopharyngitis, torsade de pointes. Fareston dosage: 40 Mg Oral. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ), SLOW K (View Slow-k Review and Slow-k Label ), ARTIST (View Artist Review and Artist Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), HALCION (View Halcion Review and Halcion Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6982088-7 | Apparent Life Threatening Event, Atrial Fibrillation, Bradycardia, Decreased Appetite, Dehydration, Electrocardiogram Qt Prolonged, Hypokalaemia, Loss Of Consciousness, Nasopharyngitis
Patient was taking Fareston (View Usage). Patient had the following side effects: apparent life threatening event, atrial fibrillation (What is atrial fibrillation?), bradycardia, decreased appetite, dehydration, electrocardiogram qt prolonged, hypokalaemia, loss of consciousness, nasopharyngitis on Aug 23, 2010 from JAPAN Additional patient health information: Female patient , 75 years of age, weighting 89.73 lb, was diagnosed with breast cancer stage i, cardiac failure and. Fareston dosage: 40 Mg Oral. During the same period patient was treated with LANIRAPID (METILDIGOXIN) (0.1 Mg Oral) (View Lanirapid (metildigoxin) Review and Lanirapid (metildigoxin) Label ), LASIX (40 Mg Oral) (View Lasix Review and Lasix Label ), SLOW K (View Slow-k Review and Slow-k Label ), ARTIST (View Artist Review and Artist Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), HALCION (View Halcion Review and Halcion Label ), WARFARIN (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6980283-4 | Dizziness
Adverse event was reported on Aug 27, 2010 by a Female patient taking Fareston (View Usage) (Dosage: 120 Mg Oral) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 68 years of age, After Fareston was administered, patient had the following side effects: dizziness (What is dizziness?).

6967515-3 | Blood Creatinine Increased, Blood Urea Increased
on Aug 09, 2010 Female patient from AUSTRALIA , 64 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased. Fareston dosage: 60 Mg, Oral. During the same period patient was treated with AVAPRO (View Avapro Review and Avapro Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ), RHINOCORT (View Rhinocort Review and Rhinocort Label ).


6946911-4 | Blood Lactate Dehydrogenase Decreased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, White Blood Cell Count Decreased
on Aug 11, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with breast cancer stage iv and was treated with Fareston (View Usage). Patient had the following side effects: blood lactate dehydrogenase decreased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, white blood cell count decreased. Fareston dosage: (120 Mg) Oral. During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6946882-0 | Deep Vein Thrombosis, Dehydration, Fall, Pulmonary Thrombosis
Patient was taking Fareston (View Usage). After Fareston was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), dehydration, fall (What is fall?), pulmonary thrombosis on Aug 09, 2010 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with breast cancer recurrent and. Fareston dosage: 120 Mg Oral. Patient was hospitalized.

6861317-4 | Blood Albumin Decreased, Blood Lactate Dehydrogenase Increased, Blood Potassium Decreased, Blood Sodium Decreased, White Blood Cell Count Decreased
Adverse event was reported on Jul 09, 2010 by a Female patient taking Fareston (View Usage) (Dosage: 120 Mg Oral) was diagnosed with breast cancer recurrent and. Location: JAPAN , 60 years of age, Patient experienced the following unwanted or unexpected effects: blood albumin decreased, blood lactate dehydrogenase increased, blood potassium decreased, blood sodium decreased, white blood cell count decreased. During the same period patient was treated with PACLITAXEL (76.8 Mg/day Intravenous) (View Paclitaxel Review and Paclitaxel Label ), HERCEPTIN (View Herceptin Review and Herceptin Label ).

6846982-X | Uterine Enlargement
on Jul 02, 2010 Female patient from JAPAN , 74 years of age, was diagnosed with breast cancer recurrent and was treated with Fareston (View Usage). Patient had the following side effects: uterine enlargement. Fareston dosage: 40 Mg Oral.

6846967-3 | Cholelithiasis, Hepatic Steatosis
on Jun 29, 2010 Female patient from JAPAN , 57 years of age, was diagnosed with breast cancer stage i and was treated with Fareston (View Usage). After Fareston was administered, patient had the following side effects: cholelithiasis, hepatic steatosis. Fareston dosage: 40 Mg; Oral. Patient was hospitalized.

6785163-5 | Blood Urea Increased, Condition Aggravated, Hepatic Failure, Metastases To Liver
Patient was taking Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: blood urea increased, condition aggravated, hepatic failure, metastases to liver on Jun 02, 2010 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with breast cancer recurrent and. Fareston dosage: 120 Mg, Oral. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), TAKEPRON (View Takepron Review and Takepron Label ), GLYCYRON (View Glycyron Review and Glycyron Label ), STRONGER NEO MINOPHAGEN C (View Stronger Neo-minophagen C Review and Stronger Neo-minophagen C Label ), AMOBAN (View Amoban Review and Amoban Label ), PIMPERAN (View Pimperan Review and Pimperan Label ).

6785162-3 | Condition Aggravated, Metastases To Liver
Adverse event was reported on Jun 04, 2010 by a Female patient taking Fareston (View Usage) (Dosage: 120 Mg, Oral) was diagnosed with breast cancer recurrent and. Location: JAPAN , 58 years of age, Patient had the following side effects: condition aggravated, metastases to liver. During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), MYSLEE (View Myslee Review and Myslee Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), EPIRUBICIN HYDROCHLORIDE (View Epirubicin Hydrochloride Review and Epirubicin Hydrochloride Label ), ZOLEDRONIC ACID HYDRATE (View Zoledronic Acid Hydrate Review and Zoledronic Acid Hydrate Label ). Patient was hospitalized.

6761381-7 | Disseminated Intravascular Coagulation, Haemorrhage, Renal Failure Acute
on May 24, 2010 Female patient from JAPAN , 73 years of age, was diagnosed with breast cancer stage iii and was treated with Fareston (View Usage). After Fareston was administered, patient had the following side effects: disseminated intravascular coagulation, haemorrhage, renal failure acute. Fareston dosage: 120 Mg; Oral. During the same period patient was treated with NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), AMLODIN (View Amlodin Review and Amlodin Label ), ARTIST (View Artist Review and Artist Label ), SIGMART (View Sigmart Review and Sigmart Label ), LASIX (View Lasix Review and Lasix Label ).

6761380-5 | Subarachnoid Haemorrhage
on Jun 01, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with breast cancer stage iv and was treated with Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: subarachnoid haemorrhage. Fareston dosage: 120 Mg; Oral.

6761379-9 | Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, White Blood Cell Count Decreased
Patient was taking Fareston (View Usage). Patient had the following side effects: blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, white blood cell count decreased on May 31, 2010 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with breast cancer stage iv and. Fareston dosage: (120 Mg); Oral. During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6761370-2 | Acute Lymphocytic Leukaemia, Blood Albumin Decreased, Blood Alkaline Phosphatase Increased, Blood Creatine Decreased, Blood Glucose Decreased, Blood Sodium Decreased, Blood Urea Decreased, Gamma-glutamyltransferase Increased, Metastases To Bone
Adverse event was reported on May 26, 2010 by a Female patient taking Fareston (View Usage) (Dosage: 120 Mg Oral) was diagnosed with breast cancer recurrent and. Location: JAPAN , 56 years of age, After Fareston was administered, patient had the following side effects: acute lymphocytic leukaemia, blood albumin decreased, blood alkaline phosphatase increased, blood creatine decreased, blood glucose decreased, blood sodium decreased, blood urea decreased, gamma-glutamyltransferase increased, metastases to bone. During the same period patient was treated with HERCEPTIN (View Herceptin Review and Herceptin Label ), ZOMETA (View Zometa Review and Zometa Label ). Patient was hospitalized.

6743586-4 | Condition Aggravated, Constipation, Uterine Leiomyoma
on May 18, 2010 Female patient from JAPAN , 78 years of age, was diagnosed with breast cancer stage iv and was treated with Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, constipation (What is constipation?), uterine leiomyoma. Fareston dosage: 120 Mg, Oral. During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), KYTRIL (View Kytril Review and Kytril Label ), DECADRON (View Decadron Review and Decadron Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), RESTAMIN (View Restamin Review and Restamin Label ), MAGMITT (View Magmitt Review and Magmitt Label ), LASIX (View Lasix Review and Lasix Label ), NEU UP (View Neu-up Review and Neu-up Label ).

6710150-2 | Acute Lymphocytic Leukaemia, Anaemia, Blood Alkaline Phosphatase Increased, Blood Creatinine Decreased, Blood Glucose Decreased, Blood Lactate Dehydrogenase Increased, Blood Urea Decreased, Gamma-glutamyltransferase Increased, Infection
on Apr 21, 2010 Female patient from JAPAN , 59 years of age, was diagnosed with breast cancer recurrent and was treated with Fareston (View Usage). Patient had the following side effects: acute lymphocytic leukaemia, anaemia, blood alkaline phosphatase increased, blood creatinine decreased, blood glucose decreased, blood lactate dehydrogenase increased, blood urea decreased, gamma-glutamyltransferase increased, infection (What is infection?). Fareston dosage: 120 Mg Oral. During the same period patient was treated with HERCEPTIN (View Herceptin Review and Herceptin Label ), ZOMETA (View Zometa Review and Zometa Label ). Patient was hospitalized.

6710149-6 | Subarachnoid Haemorrhage
Patient was taking Fareston (View Usage). After Fareston was administered, patient had the following side effects: subarachnoid haemorrhage on Apr 21, 2010 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with breast cancer stage iv and. Fareston dosage: 120 Mg Oral.

6703908-7 | Endometrial Cancer
Adverse event was reported on Apr 14, 2010 by a Female patient taking Fareston (View Usage) (Dosage: Oral) was diagnosed with breast cancer recurrent and. Location: JAPAN , 69 years of age, Patient experienced the following unwanted or unexpected effects: endometrial cancer. During the same period patient was treated with TAMOXIFEN (TAMOXIFEN) (View Tamoxifen (tamoxifen) Review and Tamoxifen (tamoxifen) Label ).

6703907-5 | Endometrial Cancer Stage Iii
on Apr 14, 2010 Female patient from JAPAN , 78 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). Patient had the following side effects: endometrial cancer stage iii. Fareston dosage: Oral.

6683585-4 | Uterine Cancer
on Mar 25, 2010 Female patient from SWITZERLAND , 71 years of age, was diagnosed with uterine cancer (What is uterine cancer?) and was treated with Fareston (View Usage). After Fareston was administered, patient had the following side effects: uterine cancer (What is uterine cancer?). Fareston dosage: Oral. During the same period patient was treated with METHOTREXATE (Intravenous) (View Methotrexate Review and Methotrexate Label ), CYCLOPHOSPHAMIDE (Intravenous) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (Intravenous) (View Fluorouracil Review and Fluorouracil Label ), DOXORUBICIN HCL (Intravenous) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), EPIRUBICIN (Intravenous) (View Epirubicin Review and Epirubicin Label ).

6681929-0 | Condition Aggravated, Malaise, Malignant Pleural Effusion, Metastases To Liver
Patient was taking Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, malaise, malignant pleural effusion, metastases to liver on Mar 29, 2010 from JAPAN Additional patient health information: Female patient , 58 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Fareston dosage: 120 Mg, Oral. During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), EPIRUBICIN HYDROCHLORIDE (View Epirubicin Hydrochloride Review and Epirubicin Hydrochloride Label ), ZOLEDRONIC ACID HYDRATE (View Zoledronic Acid Hydrate Review and Zoledronic Acid Hydrate Label ). Patient was hospitalized.

6681928-9 | Condition Aggravated, Uterine Leiomyoma
Adverse event was reported on Apr 01, 2010 by a Female patient taking Fareston (View Usage) (Dosage: 2 Tablets) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 78 years of age, Patient had the following side effects: condition aggravated, uterine leiomyoma.

6610995-3 | Refusal Of Treatment By Patient, Respiratory Failure
on Feb 15, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). After Fareston was administered, patient had the following side effects: refusal of treatment by patient, respiratory failure. Fareston dosage: 120 Mg, Oral.

6504037-8 | Subarachnoid Haemorrhage
on Dec 07, 2009 Female patient from JAPAN , 76 years of age, was diagnosed with breast cancer stage iii and was treated with Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: subarachnoid haemorrhage. Fareston dosage: 120 Mg Oral.

6442271-6 | Cystitis Haemorrhagic, Haemoglobin Decreased, Hydronephrosis, Lymphocyte Percentage Decreased, Neutrophil Percentage Increased, Platelet Count Increased, Prothrombin Time Shortened, Red Blood Cell Count Decreased, White Blood Cell Count Increased
Patient was taking Fareston (View Usage). Patient had the following side effects: cystitis haemorrhagic, haemoglobin decreased, hydronephrosis, lymphocyte percentage decreased, neutrophil percentage increased, platelet count increased, prothrombin time shortened, red blood cell count decreased, white blood cell count increased on Oct 31, 2009 from JAPAN Additional patient health information: Female patient , 65 years of age, . Fareston dosage: 120 Mg, Oral. During the same period patient was treated with ENDOXAN (50 Mg, Oral) (View Endoxan Review and Endoxan Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), SELBEX (View Selbex Review and Selbex Label ), ZOMETA (View Zometa Review and Zometa Label ).

6335645-5 | Jaundice
Adverse event was reported on Aug 17, 2009 by a Female patient taking Fareston (View Usage) (Dosage: 120 Mg Oral) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 60 years of age, After Fareston was administered, patient had the following side effects: jaundice (What is jaundice?). During the same period patient was treated with LAC B (View Lac B Review and Lac B Label ), GASTER (View Gaster Review and Gaster Label ).

6258065-0 | Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Breast Cancer Female, Gamma-glutamyltransferase Increased, Hypoalbuminaemia, Malignant Neoplasm Progression
on Jun 26, 2009 Female patient from JAPAN , 57 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, breast cancer female, gamma-glutamyltransferase increased, hypoalbuminaemia, malignant neoplasm progression. Fareston dosage: 120 Mg.

6252199-2 | Pneumonia Aspiration
on Dec 03, 2008 Female patient from JAPAN , 72 years of age, was diagnosed with breast cancer female and was treated with Fareston (View Usage). Patient had the following side effects: pneumonia aspiration. Fareston dosage: 120 Mg, Oral.

6243124-9 | Anaemia
Patient was taking Fareston (View Usage). After Fareston was administered, patient had the following side effects: anaemia on Jun 16, 2009 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Fareston dosage: 120 Mg Oral.

6243120-1 | Anaemia, Hypercalcaemia, Metastases To Bone, Renal Failure
Adverse event was reported on Jun 16, 2009 by a Female patient taking Fareston (View Usage) (Dosage: 120 Mg Oral) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 65 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, hypercalcaemia, metastases to bone, renal failure. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ALDACTON (View Aldacton Review and Aldacton Label ), ZOMETA (View Zometa Review and Zometa Label ).

6207779-7 | Carotid Artery Stenosis, Transient Ischaemic Attack
on May 12, 2009 Female patient from JAPAN , 74 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). Patient had the following side effects: carotid artery stenosis, transient ischaemic attack. Fareston dosage: 120 Mg. Patient was hospitalized.

6185181-4 | Coma Hepatic, Hepatic Failure
on Apr 28, 2009 Female patient from JAPAN , 83 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). After Fareston was administered, patient had the following side effects: coma hepatic, hepatic failure. Fareston dosage: 40 Mg , Oral. During the same period patient was treated with EUGLUCON (View Euglucon Review and Euglucon Label ).

6172932-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Jaundice
Patient was taking Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, jaundice (What is jaundice?) on Apr 17, 2009 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Fareston dosage: 120 Mg Oral.

6129165-0 | Dyspnoea, Pleural Effusion
Adverse event was reported on Mar 09, 2009 by a Female patient taking Fareston (View Usage) (Dosage: 120 Mg) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 50 years of age, Patient had the following side effects: dyspnoea, pleural effusion. During the same period patient was treated with LOXOSININ (View Loxosinin Review and Loxosinin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), CYTOTEC (View Cytotec Review and Cytotec Label ). Patient was hospitalized.

5960339-5 | Hepatic Function Abnormal
on Nov 12, 2008 Female patient from JAPAN , 65 years of age, was diagnosed with breast cancer stage iv and was treated with Fareston (View Usage). After Fareston was administered, patient had the following side effects: hepatic function abnormal. Fareston dosage: 120 Mg Oral.

5902989-8 | Myelodysplastic Syndrome
on Sep 18, 2008 Female patient from JAPAN , 63 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: myelodysplastic syndrome. Fareston dosage: 40 Mg, Oral. During the same period patient was treated with TOLTERODINE TARTRATE (View Tolterodine Tartrate Review and Tolterodine Tartrate Label ), VESICAR (SOLIFENACIN) (View Vesicar (solifenacin) Review and Vesicar (solifenacin) Label ), MAGLAX (View Maglax Review and Maglax Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), SELBEX (View Selbex Review and Selbex Label ). Patient was hospitalized.

5832200-8 | Dysphonia, Interstitial Lung Disease, Nasopharyngitis
Patient was taking Fareston (View Usage). Patient had the following side effects: dysphonia, interstitial lung disease, nasopharyngitis on Jul 22, 2008 from JAPAN Additional patient health information: Female patient , 66 years of age, was diagnosed with breast cancer stage iii and. Fareston dosage: 120 Mg, Oral. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), MOSAPRAMINE (View Mosapramine Review and Mosapramine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SENNA LEAF/POD (View Senna Leaf/pod Review and Senna Leaf/pod Label ).

5821762-2 | Cervical Dysplasia, Endometrial Dysplasia, Endometrial Hypertrophy, Uterine Enlargement, Uterine Polyp
Adverse event was reported on Jul 07, 2008 by a Female patient taking Fareston (View Usage) (Dosage: 120 Mg Oral, 120 Mg Oral, 80 Mg Oral) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 72 years of age, After Fareston was administered, patient had the following side effects: cervical dysplasia, endometrial dysplasia, endometrial hypertrophy, uterine enlargement, uterine polyp. During the same period patient was treated with EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), AZASETRON (View Azasetron Review and Azasetron Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

5817686-7 | Back Pain, Bone Pain, C-reactive Protein Increased, Impaired Work Ability, Pelvic Pain, Pyrexia
on Jul 10, 2008 Female patient from JAPAN , 55 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), bone pain, c-reactive protein increased, impaired work ability, pelvic pain (What is pelvic pain?), pyrexia. Fareston dosage: 120 Mg Oral. During the same period patient was treated with ZOLEDRONIC ACID (4 Mg, Oral) (View Zoledronic Acid Review and Zoledronic Acid Label ). Patient was hospitalized.

5786825-9 | Pancytopenia
on Jun 04, 2008 Female patient from JAPAN , 60 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). Patient had the following side effects: pancytopenia. Fareston dosage: 40 Mg, Oral. Patient was hospitalized.

5786824-7 | Pancytopenia
Patient was taking Fareston (View Usage). After Fareston was administered, patient had the following side effects: pancytopenia on Jun 10, 2008 from JAPAN Additional patient health information: Female patient , 63 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Fareston dosage: 40 Mg, Oral. During the same period patient was treated with TOLTERODINE TARTRATE (View Tolterodine Tartrate Review and Tolterodine Tartrate Label ), VESICAR (SOLIFENACIN) (View Vesicar (solifenacin) Review and Vesicar (solifenacin) Label ), MAGLAX (View Maglax Review and Maglax Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), SELBEX (View Selbex Review and Selbex Label ). Patient was hospitalized.

5642659-7 | Acute Hepatic Failure
Adverse event was reported on Feb 05, 2008 by a Female patient taking Fareston (View Usage) (Dosage: 120 Mg Oral) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 35 years of age, Patient experienced the following unwanted or unexpected effects: acute hepatic failure. Patient was hospitalized.

5615257-9 | Hepatic Function Abnormal
on Jan 07, 2008 Female patient from JAPAN , 57 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). Patient had the following side effects: hepatic function abnormal. Fareston dosage: 40 Mg Oral. Patient was hospitalized.

5486022-0 | Acute Myeloid Leukaemia
on Sep 17, 2007 Female patient from SWITZERLAND , 70 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). After Fareston was administered, patient had the following side effects: acute myeloid leukaemia. Fareston dosage: .

5450982-4 | Blood Glucose Increased
Patient was taking Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased on Aug 31, 2007 from JAPAN Additional patient health information: Female patient , 79 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Fareston dosage: 120 Mg, Oral. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), BERIZYM (View Berizym Review and Berizym Label ), MAZULENE (AZULENE SULFONATE SODIUM) (View Mazulene (azulene Sulfonate-sodium) Review and Mazulene (azulene Sulfonate-sodium) Label ).

5338095-3 | Abdominal Pain, Abdominal Pain Upper, Abscess, Abscess Jaw, Arteriosclerosis, Back Pain, Bone Disorder, Bone Trimming, Breath Odour
Adverse event was reported on May 24, 2007 by a Female patient taking Fareston (View Usage) (Dosage: ) . Location: UNITED STATES , 52 years of age, weighting 220.0 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal pain upper, abscess (What is abscess?), abscess jaw, arteriosclerosis, back pain (What is back pain?), bone disorder, bone trimming, breath odour. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), MAGNESIUM CARBONATE (View Magnesium Carbonate Review and Magnesium Carbonate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AREDIA (View Aredia Review and Aredia Label ), ZOMETA (Unk, Qmo) (View Zometa Review and Zometa Label ).

5337501-8 | Portal Hypertension, Portal Vein Occlusion, Portal Vein Stenosis, Varices Oesophageal
on May 17, 2007 Female patient from JAPAN , 72 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). After Fareston was administered, patient had the following side effects: portal hypertension, portal vein occlusion, portal vein stenosis, varices oesophageal. Fareston dosage: Oral. During the same period patient was treated with ASPIRIN/DIALIMINATE (View Aspirin/dialiminate Review and Aspirin/dialiminate Label ), MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ).

5332101-8 | Acute Hepatic Failure
on May 10, 2007 Female patient from JAPAN , 35 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Fareston (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure. Fareston dosage: 120 Mg. During the same period patient was treated with TAXOL (120 Mg) (View Taxol Review and Taxol Label ). Patient was hospitalized.

5332100-6 | Eosinophil Count Increased, Hepatocellular Damage
Patient was taking Fareston (View Usage). Patient had the following side effects: eosinophil count increased, hepatocellular damage on May 11, 2007 from JAPAN Additional patient health information: Female patient , 82 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Fareston dosage: 40 Mg.